II 

109TH CONGRESS 

1ST SESSION S. 36

To amend title 10, United States Code, to recognize the United States 

Military Cancer Institute as an establishment within the Uniformed Services University of the Health Sciences, to require the Institute to promote 

the health of members of the Armed Forces and their dependents by 

enhancing cancer research and treatment, to provide for a study of 

the epidemiological causes of cancer among various ethnic groups for 

cancer prevention and early detection efforts, and for other purposes. 

IN THE SENATE OF THE UNITED STATES 

JANUARY 24, 2005

Mr. INOUYE introduced the following bill; which was read twice and referred 

to the Committee on Armed Services 

A BILL

To amend title 10, United States Code, to recognize the 

United States Military Cancer Institute as an establishment within the Uniformed Services University of the 

Health Sciences, to require the Institute to promote the 

health of members of the Armed Forces and their dependents by enhancing cancer research and treatment, 

to provide for a study of the epidemiological causes of 

cancer among various ethnic groups for cancer prevention and early detection efforts, and for other purposes.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,
2

•S 36 IS 

1 SECTION 1. THE UNITED STATES MILITARY CANCER INSTI2 TUTE. 

3 (a) ESTABLISHMENT.—Chapter 104 of title 10, 

4 United States Code, is amended by adding at the end the 

5 following new section: 

6 ‘‘§ 2117. United States Military Cancer Institute 

7 ‘‘(a) ESTABLISHMENT.—(1) There is a United States 

8 Military Cancer Institute in the University. The Director 

9 of the United States Military Cancer Institute is the head 

10 of the Institute. 

11 ‘‘(2) The Institute is composed of clinical and basic 

12 scientists in the Department of Defense who have an ex13 pertise in research, patient care, and education relating 

14 to oncology and who meet applicable criteria for participa15 tion in the Institute. 

16 ‘‘(3) The components of the Institute include military 

17 treatment and research facilities that meet applicable cri18 teria and are designated as affiliates of the Institute. 

19 ‘‘(b) RESEARCH.—(1) The Director of the United 

20 States Military Cancer Institute shall carry out research 

21 studies on the following: 

22 ‘‘(A) The epidemiological features of cancer, in23 cluding assessments of the carcinogenic effect of ge24 netic and environmental factors, and of disparities in 

25 health, inherent or common among populations of 

26 various ethnic origins. 
3

•S 36 IS 

1 ‘‘(B) The prevention and early detection of can2 cer. 

3 ‘‘(C) Basic, translational, and clinical investiga4 tion matters relating to the matters described in 

5 subparagraphs (A) and (B). 

6 ‘‘(2) The research studies under paragraph (1) shall 

7 include complementary research on oncologic nursing. 

8 ‘‘(c) COLLABORATIVE RESEARCH.—The Director of 

9 the United States Military Cancer Institute shall carry out 

10 the research studies under subsection (b) in collaboration 

11 with other cancer research organizations and entities se12 lected by the Institute for purposes of the research studies. 

13 ‘‘(d) ANNUAL REPORT.—(1) Promptly after the end 

14 of each fiscal year, the Director of the United States Mili15 tary Cancer Institute shall submit to the President of the 

16 University a report on the results of the research studies 

17 carried out under subsection (b). 

18 ‘‘(2) Not later than 60 days after receiving the an19 nual report under paragraph (1), the President of the Uni20 versity shall transmit such report to the Secretary of De21 fense and to Congress.’’. 

22 (b) CLERICAL AMENDMENT.—The table of sections 

23 at the beginning of such chapter is amended by adding 

24 at the end the following new item:

‘‘2117. United States Military Cancer Institute.’’.

Æ